Trending

Catalyst Pharmaceuticals

Catalyst defends huge US price hike for rare disease drug

Catalyst defends huge US price hike for rare disease drug

Catalyst Pharmaceuticals has defended hiking the price of the rare disease drug Firdapse (amifampridine) from virtually nothing to

X

Catalyst defends huge US price hike for rare disease drug

https://pharmaphorum.com/news/catalyst-defends-huge-us-price-hike-for-rare-disease-drug/

Catalyst to re-submit rare disease drug after trial success

Catalyst to re-submit rare disease drug after trial success

Already approved in EU, Catalyst aiming for FDA filing next year.

X

Catalyst to re-submit rare disease drug after trial success

https://pharmaphorum.com/news/catalyst-us-filing-lems-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com